Abstract
Purpose
There are scarce data describing the outcomes of hospitalized patients admitted with inflammatory bowel disease (IBD) stratified by race. In this retrospective cohort study, we evaluated the difference in outcomes between adult white and black patients hospitalized with a principal diagnosis of inflammatory bowel disease.
Methods
Data were obtained from the 2016 and 2017 National Inpatient Sample (NIS) database. Our primary outcome was inpatient mortality while the secondary outcomes were hospital length of stay (LOS), total hospital charges (THC), red blood cell (RBC) transfusion, diagnosis of bowel perforation, and severe sepsis with septic shock. We conducted the analysis using STATA software. We used propensity-matched multivariate regression analysis to adjust for potential confounders.
Results
Among 71 million hospital hospitalizations, we found 177,574 hospitalizations with a principal diagnosis of IBD, with 24,635 (13.9%) for black patients, 124,899 (70.3%) for white patients, and 28,040 (15.8%) were for others. There was no significant difference in inpatient mortality for black vs white patients. Among secondary outcomes, white compared to black patients had increased odds of having a diagnosis of bowel perforation when admitted with a diagnosis of IBD while there was no difference in the odds of developing septic shock. White patients admitted with a diagnosis of UC were also found to have increased total LOS and THC.
Conclusion
White patients hospitalized with a principal diagnosis of IBD had no difference in inpatient mortality or septic shock but had worse outcomes such as increased odds of bowel perforation compared to black patients.
Similar content being viewed by others
References
Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB (2016) Prevalence of inflammatory bowel disease among adults aged ≥18 years — United States, 2015. MMWR Morb Mortal Wkly Rep 65(42):1166–1169. https://doi.org/10.15585/mmwr.mm6542a3. (PMID: 27787492)
Hwang JM, Varma MG (2008) Surgery for inflammatory bowel disease. World J Gastroenterol 14(17):2678–2690. https://doi.org/10.3748/wjg.14.2678. (PMID: 18461653; PMCID: PMC2709047)
Sewell JL, Yee HF Jr, Inadomi JM (2010) Hospitalizations are increasing among minority patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 16(2):204–207. https://doi.org/10.1002/ibd.21008. (PMID: 19575353)
Aniwan S, Harmsen WS, Tremaine WJ, Loftus EV Jr (2019) Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol 6(12):1756284819827692. https://doi.org/10.1177/1756284819827692. (PMID: 30792818; PMCID: PMC6376543)
Veluswamy H, Suryawala K, Sheth A, Wells S, Salvatierra E, Cromer W, Chaitanya GV, Painter A, Patel M, Manas K, Zwank E, Boktor M, Baig K, Datti B, Mathis MJ, Minagar A, Jordan PA, Alexander JS (2010) African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol 9(10):104. https://doi.org/10.1186/1471-230X-10-104. (PMID: 20828408; PMCID: PMC2944337)
Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM (1992) Crohn’s disease among ethnic groups in a large health maintenance organization. Gastroenterology 102(6):1940–1948. https://doi.org/10.1016/0016-5085(92)90317-r. (PMID: 1587413)
Vespa J, Medina L, Armstrong DM (2018) Demographic turning points for the United States: population projections for 2020 to 2060. Retrieved April 12, 2021, from https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144.pdf
Afzali A, Cross RK (2016) Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis 22(8):2023–2040. https://doi.org/10.1097/MIB.0000000000000835. (PMID: 27379446)
Kaplan GG, Windsor JW (2021) The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 18(1):56–66. https://doi.org/10.1038/s41575-020-00360-x. (Epub 2020 Oct 8 PMID: 33033392; PMCID: PMC7542092)
Xu F, Wheaton AG, Liu Y, Lu H, Greenlund KJ (2019) Hospitalizations for inflammatory bowel disease among Medicare fee-for-service beneficiaries — United States, 1999–2017. MMWR Morb Mortal Wkly Rep 68(49):1134–1138. https://doi.org/10.15585/mmwr.mm6849a2. (PMID: 31830006; PMCID: PMC6919289)
Straus WL, Eisen GM, Sandler RS, Murray SC, Sessions JT (2000) Crohn’s disease: does race matter? The Mid-Atlantic Crohn’s Disease Study Group Am J Gastroenterol 95(2):479–483. https://doi.org/10.1111/j.1572-0241.2000.t01-1-01531.x. (PMID: 10685754)
Basu D, Lopez I, Kulkarni A, Sellin JH (2005) Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 100(10):2254–2261. https://doi.org/10.1111/j.1572-0241.2005.00233.x. (PMID: 16181378)
Montgomery SR Jr, Butler PD, Wirtalla CJ, Collier KT, Hoffman RL, Aarons CB, Damrauer SM, Kelz RR (2018) Racial disparities in surgical outcomes of patients with inflammatory bowel disease. Am J Surg 215(6):1046–1050. https://doi.org/10.1016/j.amjsurg.2018.05.011. (Epub 2018 May 12 PMID: 29803499; PMCID: PMC7764563)
Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV (2015) Racial disparities in readmission, complications, and procedures in children with Crohn’s disease. Inflamm Bowel Dis 21(4):801–808. https://doi.org/10.1097/MIB.0000000000000325. (PMID: 25742396; PMCID: PMC4366277)
Nguyen GC, Chong CA, Chong RY (2014) National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis 8(4):288–295. https://doi.org/10.1016/j.crohns.2013.09.001. (Epub 2013 Sep 24 PMID: 24074875)
Ojemolon PE, Shaka H, Edigin E, Gomez TMA, Eseaton P, Bello J, Azubuike C, Adekola OP (2020) Impact of diabetes mellitus on outcomes of patients with knee osteoarthritis who underwent knee arthroplasty: an analysis of the nationwide inpatient sample. Cureus 12(6). https://doi.org/10.7759/cureus.8902. (PMID: 32742869; PMCID: PMC7389248)
Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163(3):262–270. https://doi.org/10.1093/aje/kwj047. (Epub 2005 Dec 21 PMID: 16371515)
Gunnells DJ Jr, Morris MS, DeRussy A, Gullick AA, Malik TA, Cannon JA, Hawn MT, Chu DI (2016) Racial disparities in readmissions for patients with inflammatory bowel disease (IBD) after colorectal surgery. J Gastrointest Surg 20(5):985–993. https://doi.org/10.1007/s11605-015-3068-9. (Epub 2016 Jan 7 PMID: 26743885)
Walker C, Allamneni C, Orr J, Yun H, Fitzmorris P, Xie F, Malik TA (2018) Socioeconomic status and race are both Independently associated with increased hospitalization rate among Crohn’s disease patients. Sci Rep 8(1):4028. https://doi.org/10.1038/s41598-018-22429-z. (PMID: 29507339; PMCID: PMC5838155)
Braveman P, Gottlieb L (2014) The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep 129(Suppl 2):19–31. https://doi.org/10.1177/00333549141291S206. (PMID: 24385661; PMCID: PMC3863696)
Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR (2009) Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 15(8):1233–1239. https://doi.org/10.1002/ibd.20883. (PMID: 19177509; PMCID: PMC2799328)
Wang EC, Choe MC, Meara JG, Koempel JA (2004) Inequality of access to surgical specialty health care: why children with government-funded insurance have less access than those with private insurance in Southern California. Pediatrics 114(5):e584–e590. https://doi.org/10.1542/peds.2004-0210. (PMID: 15520090)
Medicaid Access Study Group (1994) Access of Medicaid recipients to outpatient care. N Engl J Med 330(20):1426–1430. https://doi.org/10.1056/NEJM199405193302007. (PMID: 8159198)
Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS (2018) Lack of difference in treatment patterns and clinical outcomes between black and white patients with inflammatory bowel disease. Inflamm Bowel Dis 24(12):2634–2640. https://doi.org/10.1093/ibd/izy179. (PMID:29788063;PMCID:PMC6262194)
Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S (2008) Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis 14(7):960–967. https://doi.org/10.1002/ibd.20389. (PMID: 18266229)
Nguyen GC, Bayless TM, Powe NR, Laveist TA, Brant SR (2007) Race and health insurance are predictors of hospitalized Crohn’s disease patients undergoing bowel resection. Inflamm Bowel Dis 13(11):1408–1416. https://doi.org/10.1002/ibd.20200. (PMID: 17567876)
Nguyen GC, Laveist TA, Gearhart S, Bayless TM, Brant SR (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4(12):1507–1513. https://doi.org/10.1016/j.cgh.2006.09.026. Erratum In: Clin Gastroenterol Hepatol (2007) 5(6):765. (PMID: 17162242)
Cross RK, Jung C, Wasan S, Joshi G, Sawyer R, Roghmann MC (2006) Racial differences in disease phenotypes in patients with Crohn’s disease. Inflamm Bowel Dis 12(3):192–198. https://doi.org/10.1097/01.MIB.0000217767.98389.20. (PMID: 16534420)
Moore L, Gaffney K, Lopez R, Shen B (2012) Comparison of the natural history of ulcerative colitis in African Americans and non-Hispanic Caucasians: a historical cohort study. Inflamm Bowel Dis 18(4):743–749. https://doi.org/10.1002/ibd.21796. (Epub 2011 Jun 17 PMID: 21688351)
Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, Hanauer SB, Hanson J, Harris ML, Kane SV, Orkwis HK, Lahaie R, Oliva-Hemker M, Pare P, Wild GE, Rioux JD, Yang H, Duerr RH, Cho JH, Steinhart AH, Brant SR, Silverberg MS (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol 101(5):1012–1023. https://doi.org/10.1111/j.1572-0241.2006.00504.x. (PMID: 16696785)
Pola S, Patel D, Ramamoorthy S, McLemore E, Fahmy M, Rivera-Nieves J, Chang JT, Evans E, Docherty M, Talamini M, Sandborn WJ (2012) Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol 10(12):1315–1325.e4. https://doi.org/10.1016/j.cgh.2012.07.006. (Epub 2012 Jul 24 PMID: 22835577; PMCID: PMC4226798)
Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, Nebel J, Kofman G, Noel R, Broeckel U, Tolia V (2005) Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn’s disease. Inflamm Bowel Dis 11(7):631–638. https://doi.org/10.1097/01.mib.0000171279.05471.21. (PMID: 15973116)
Flasar MH, Johnson T, Roghmann MC, Cross RK (2008) Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis 14(1):13–19. https://doi.org/10.1002/ibd.20298. (PMID: 17973305)
Makkar R, Bo S (2013) Colonoscopic perforation in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 9(9):573–83. (PMID: 24729766; PMCID: PMC3983974)
Navaneethan U, Kochhar G, Phull H, Venkatesh PG, Remzi FH, Kiran RP, Shen B (2012) Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients. J Crohns Colitis 6(4):470–475. https://doi.org/10.1016/j.crohns.2011.10.005. (Epub 2011 Nov 17 PMID: 22398061)
Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT (2020) Inpatient management of inflammatory bowel disease-related complications. Clin Gastroenterol Hepatol 18(6):1346–1355. https://doi.org/10.1016/j.cgh.2019.12.040. (Epub 2020 Jan 9 PMID: 31927105)
Edigin E, Ojemolon PE, Eseaton PO, Jamal S, Shaka H, Akuna E, Asemota IR, Manadan A (2020) Systemic sclerosis is associated with increased inpatient mortality in patients admitted for acute coronary syndrome: analysis of the National Inpatient Sample. J Clin Rheumatol 1. https://doi.org/10.1097/RHU.0000000000001634. (Epub ahead of print. PMID: 33264253)
Edigin E, Asotibe J, Eseaton PO, Busari OA, Achebe I, Kichloo A, Jamal S, Patel A (2021) Coexisting psoriasis is associated with an increased risk of hospitalization for patients with inflammatory bowel disease: an analysis of the National inpatient sample database. J Investig Med 69(4):857-62. https://doi.org/10.1136/jim-2020-001689. (Epub ahead of print. PMID: 33361402)
Author information
Authors and Affiliations
Contributions
Jennifer C Asotibe MD and Emmanuel Akuna MD are credited with the conception of the study, design of the study, acquisition of data, interpretation of the data, revision of intellectual content, and final approval of the submitted version of the manuscript. Dimeji Williams MD, Olukayode A Busari MD, and Ehizogie Edigin MD are credited with the drafting of the manuscript, interpretation of the data, discussion of relevant data, and extensive literature review. Ikechukwu Achebe MD and Brenda Mishael Asotibe MD are credited with the literature review and revision of intellectual content for the manuscript. Williams Trick MD and Satya Mishra MD are credited with literature review, critical revision of the manuscript, and approval of final submitted manuscript.
Corresponding author
Ethics declarations
Ethics approval
This manuscript is exempted from IRB approval as it involves data without patient identifiers.
Consent to participate
Not applicable.
Consent for publication
Participating authors grant permission for publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Asotibe, J.C., Akuna, E., Williams, D. et al. Racial differences in the outcomes of IBD hospitalizations: a national population-based study. Int J Colorectal Dis 37, 221–229 (2022). https://doi.org/10.1007/s00384-021-04052-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-021-04052-z